Riskpilot← Back to searchSign inGet full accessBJØNNESLEGENE AS
ASActiveOrg 931733362Frolandsveien 6, 4847 ArendalGeneral medical practice activities · NACE 8621Est. 202318 employees
Revenue 2024
NOK 7,3M
+12% vs 2023
EBITDA margin
-0.6%
-112% vs 2023
Equity ratio
41.7%
Financial strength
Net profit 2024
NOK -203K
-215% vs 2023
| Revenue | NOK 7,3M | +12% |
| EBITDA | NOK -41K | -112% |
| Net profit | NOK -203K | -215% |
| Total assets | NOK 1,8M | +1% |
| Equity | NOK 754K | +85% |
| Employees | 18 | — |
Legal name
BJØNNESLEGENE AS
Org number
931733362
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
19. juli 2023
Share capital
NOK 330 000
Employees
18 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder og ett styremedlem i fellesskap.
Company purpose
Drifte og forvalte felles legekontor for selskapets eiere samt det som naturlig står i forbindelse med dette.
Address
Frolandsveien 6, 4847 Arendal
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | 6 485 | 7 257 |
| Staff expenses | −3 090 | −3 801 |
| EBITDA | 351 | −41 |
| Depreciation & amort. | −165 | −164 |
| EBIT | 186 | −205 |
| Net financials | 40 | 2 |
| Profit before tax | 226 | −203 |
| Tax | 50 | −0 |
| Net profit | 176 | −203 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 1 784 | 1 807 |
| Equity | 407 | 754 |
| Long-term debt | 0 | 0 |
| Short-term debt | 1 377 | 1 053 |
| Total debt | 1 377 | 1 053 |
EBITDA margin
-0.6%
This company
15.8%
Market median
-104% vs market
20232024
Equity ratio
41.7%
This company
38.2%
Market median
+9% vs market
20232024
Return on equity
-27.0%
This company
18.4%
Market median
-247% vs market
20232024
Net profit margin
-2.8%
This company
8.1%
Market median
-135% vs market
20232024
Asset turnover
4.02×
This company
1.12×
Market median
+259% vs market
20232024
Debt / equity
1.40×
This company
0.62×
Market median
-126% vs market
20232024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BP Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2023 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2026 | — | — | |
| Chairman | 2026 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Lege Lars Christian Kvalbein-Olsen As | Company | 12.5% | 12.5% | 2024 |
Lege Elisabeth Bruflodt Stenhagen As | Company | 12.5% | 12.5% | 2024 |
Lege Hildur Gudmundsdottir As | Company | 12.5% | 12.5% | 2024 |
| Individual | 12.5% | 12.5% | 2024 | |
| Individual | 12.5% | 12.5% | 2024 | |
| Individual | 12.5% | 12.5% | 2024 | |
Monika Praljak Voigt As | Company | 12.5% | 12.5% | 2024 |
Dr. Siri Dalsmo Berge As | Company | 12.5% | 12.5% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BJØNNESLEGENE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Boris Praljak | Chief Executive Officer | 0 companies |
| Siri Dalsmo Berge | Chairman | 0 companies |
| Hildur Gudmundsdottir | Board of Directors | 0 companies |
| Lars Christian Kvalbein-Olsen | Board of Directors | 0 companies |
| Marthe Haugland Evensen | Board of Directors | 0 companies |
| Monika Praljak Voigt | Board of Directors | 0 companies |
| Martin Michelsen Lysaker | Board of Directors | 0 companies |
| Elisabeth Bruflodt Stenhagen | Chairman | 0 companies |
| Oliver Scheck | Board of Directors | 0 companies |